EP2976096
INSULIN DOSING REGIMEN
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
19.3.2014EP published:
27.2.2019EP application number:
14713072.8
EPO information:
European Patent Register
Max expiry date:
18.3.2034
Title:
INSULIN DOSING REGIMEN
Timeline
Today
19.3.2014EP application
27.2.2019EP Publication
Owner
Name:
Novo Nordisk A/SAddress:
Novo Allé, 2880, Bagsværd, DK
Inventor
Name:
JOHANSEN, ThueAddress:
Bagsvaerd, DK
Priority
Number:
13160194Date:
20.3.2013Country:
EP
Number:
201361804363 PDate:
22.3.2013Country:
US
Classification
Categories:
A61K 9/00, A61K 38/28